已发表论文

巨噬细胞衍生的外泌体作为先进的炎症治疗药物:当前进展和未来前景

 

Authors Song Y , Hu J , Ma C, Liu H, Li Z, Yang Y 

Received 22 November 2023

Accepted for publication 10 February 2024

Published 19 February 2024 Volume 2024:19 Pages 1597—1627

DOI https://doi.org/10.2147/IJN.S449388

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 3

Editor who approved publication: Professor Lei Yang

Abstract: The development of numerous diseases is significantly influenced by inflammation. Macrophage-derived exosomes (M-Exos) play a role in controlling inflammatory reactions in various conditions, including chronic inflammatory pain, hypertension, and diabetes. However, the specific targets and roles of M-Exos in regulating inflammation in diseases remain largely unknown. This review summarizes current knowledge on M-Exos biogenesis and provides updated information on M-Exos’ biological function in inflammation modulation. Furthermore, this review highlights the functionalization and engineering strategies of M-Exos, while providing an overview of cutting-edge approaches to engineering M-Exos and advancements in their application as therapeutics for inflammation modulation. Finally, multiple engineering strategies and mechanisms are presented in this review along with their perspectives and challenges, and the potential contribution that M-Exos may have in diseases through the modulation of inflammation is discussed.

Keywords: inflammation, macrophage-derived exosomes, biological functions, inflammation modulation, engineering strategies